Molybdenum-99 Program
Active
- Assistance listing
- 81.009
- Agency
-
Department of Energy
- Grant awards
- 4 $108,491,010 in federal obligations
Program facts
- Also known as
- Technology for Demonstration and Commercial Scale Production of a Reliable, Domestic Supply of Molybdenum-99 without the Use of Highly Enriched Uranium
- Assistance type
-
- Cooperative Agreement
- Treasury account
-
- 89-0309-0-1-053
- More information
Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.
About this program
The Department of Energy National Nuclear Security Administration administers the Molybdenum-99 Program (CFDA 81.009) to support domestic production of molybdenum-99 without highly enriched uranium, with the most recent grant awards made in December 2021.
Program activity has concluded. Four Cooperative Agreements totaling $108.5 million in federal obligations were awarded in September and October 2021, with ultimate completion dates ranging from December 2024 to July 2027. The source explicitly states that no additional funding opportunities are currently open or planned to be issued under this Assistance Listing. The previous FOA closed September 30, 2020.
The program funds commercial-scale production infrastructure and technology development for non-HEU-based molybdenum-99 production. Recent awards supported diverse technical approaches: SHINE Technologies received $172.1 million to establish high-specific-activity Mo-99 production; NorthStar Medical Radioisotopes received $32.6 million for neutron-capture-based production using enriched molybdenum-98, including automated dissolution and quality-control systems at its Beloit, Wisconsin and MURR facilities; NorthStar also received $55.4 million for electron-accelerator irradiation using enriched molybdenum-100 with expanded production facilities; and NIOWAVE received $17.2 million to advance toward commercial-scale production at 10 kilocuries per week.
All four awards were Cooperative Agreements from the National Nuclear Security Administration, representing 100 percent of the portfolio. Recipients contributed $168.8 million in non-federal cost-share against federal obligations of $108.5 million, for combined obligations of $277.3 million.
This program is no longer actively soliciting applications. Organizations interested in Mo-99 production should monitor DOE/NNSA for any future solicitation, though the source indicates no new FOAs are planned under this Assistance Listing.
Objective and description
- Objective
In 2012, Congress passed the American Medical Isotopes Production Act (AMIPA), which directed the Department of Energy to establish a technology-neutral program to support the establishment of domestic supplies of molybdenum-99 (Mo-99) without the us
- Description
Accelerating the establishment of commercial non-HEU-based Mo-99 production in the United States.
Eligibility
- Applicant eligibility
Only U.S. commercial entities with mature technologies to achieve commercial-scale production of Mo-99 in a facility or using facilities located in the United States in accordance with the goals of this FOA may submit applications. National Laboratories, M & O Contractors, Institutions of Higher Education, and Federally Funded Research and Development Centers (FFRDC) are not eligible to apply for an award under this FOA, but can be included in teaming arrangements.
- Beneficiary eligibility
The general public.
- Credentials and documentation
For Non-government organizations, Costs will be determined in accordance with OMB Circular No. A-122 . 2 CFR 200, Subpart E - Cost Principles applies to this program.
- Uses of assistance
The technical objective of the assistance is to achieve near term U.S. commercial Mo-99 production of at least 1,500 6-day Ci/week without the use of HEU and the ability to increase the production of Mo-99 in its facility or facilities up to 3,000 6-day Ci/week.
- Length and time phasing of assistance
Generally, agreements are approved for two-year or five year project periods and either fully funded or funded per budget period, depending on budget appropriation, at the discretion of the program office.
How to apply
- Preapplication coordination
Preapplication coordination is required. An environmental impact statement is required for this listing. This program is excluded from coverage under E.O. 12372.
- Application procedure
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. No additional FOAs are currently open or planned to be issued under this Assistance Listing. The previous FOA was posted on Grants.gov (opens in new window) and applicants were required to submit applications through that website to be considered for award. All applications that were received by the application due date and time, as specified in the FOA, were subjected to an initial Compliance Review, and upon satisfactorily passing the initial review were subjected to a comprehensive evaluation.
- Criteria for selecting proposals
All timely applications under the previous FOA that satisfactorily passed the initial compliance review were eligible for a comprehensive merit review. Prior to conducting the comprehensive merit review, an initial review was performed to determine whether: (1) the applicant is eligible for award; (2) the information required by the FOA has been submitted; (3) all other mandatory requirements of the FOA are satisfied; and (4) the proposed project is responsive to the program objectives of the FOA. This review is a thorough, consistent, and objective examination of applications based on the pre-established evaluation criteria set forth in the FOA. Each application was evaluated on the strengths and weaknesses it exhibited in relation to scientific and technological merit; technical approach; and business strategy and management capabilities.
- Award procedure
The Merit Review Panel Chairperson was responsible for reviewing the independent findings and ratings of each evaluator, and ultimately completing a Merit Review Panel Chairperson's Report to summarize the findings and make recommendations for awards to the Selection Official. The Selection Official considered the merit review recommendation, program policy factors, budget evaluations of the Project Management Plan, and the amount of funds available, when making a decision for awards. The program policy factors and budget evaluations were not point scored, but the Selection Official could consider them in making the selections for negotiation of award. The Selection Official made a decision to select for award a group of projects which represented a diversity of technical approaches, methods, applications and/or market segments, which included four awards. Upon the Selection Official making the final decisions, the Contracting Officer notified selectees and non-selectees.
- Deadlines
No additional FOAs are currently open or planned to be issued under this Assistance Listing. The previous FOA was open for 60 days.
- Time to approval or disapproval
30 Days - Selection Process 135 Days - Prepare for Award/Negotiate/Award 1 - 4 Cooperative Agreements
Grant opportunities
| Opportunity | Status | Posted | Applications due |
|---|---|---|---|
| Commercial Domestic Production of Moly-99 without the Use of Highly Enriched Uranium | Closed |
Grant awards
Top recipients by federal obligations
| Rank | Recipient | Federal obligations | Share |
|---|---|---|---|
| 1 | Shine Technologies, LLC | $87,274,432 | 80% |
| 2 | Northstar Medical Technologies, LLC | $17,021,679 | 16% |
| 3 | Niowave, Inc. | $4,194,899 | 4% |
Federal obligations by fiscal year
| Fiscal year | Federal obligations |
|---|---|
| FY2026 | $8,693,090 |
| FY2024 | $797,920 |
| FY2022 | $62,000,000 |
| FY2021 | $37,000,000 |
Quick answers
What is Assistance Listing 81.009?
Assistance Listing 81.009 is Molybdenum-99 Program, a federal grant program run by Department of Energy.
What is the CFDA number for Molybdenum-99 Program?
Its CFDA number is 81.009: Assistance Listing numbers were called CFDA numbers before 2018.
How much funding has Assistance Listing 81.009 awarded?
4 grant awards under 81.009 have obligated $108,491,010 in federal funds to 3 recipients.
Who receives the most funding from 81.009?
The recipients obligated the most under Molybdenum-99 Program are Shine Technologies, LLC ($87,274,432), Northstar Medical Technologies, LLC ($17,021,679) and Niowave, Inc. ($4,194,899).
Are there open grant opportunities under 81.009?
No opportunity listed under 81.009 is open now. The latest, Commercial Domestic Production of Moly-99 without the Use of Highly Enriched Uranium, was posted on July 31, 2020.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program